MCID: SBR004
MIFTS: 41

Seborrheic Dermatitis

Categories: Skin diseases

Aliases & Classifications for Seborrheic Dermatitis

MalaCards integrated aliases for Seborrheic Dermatitis:

Name: Seborrheic Dermatitis 12 37 29 55 15 73
Seborrhoeic Dermatitis 12
Dermatitis, Seborrheic 44
Seborrhoeic Eczema 12
Skin Seborrheic 12
Seborrhea 12

Classifications:



External Ids:

Disease Ontology 12 DOID:8741
ICD10 33 L21 L21.9
ICD9CM 35 690.1 690.10 706.3
MeSH 44 D012628
NCIt 50 C111888
KEGG 37 H01652
UMLS 73 C0036508

Summaries for Seborrheic Dermatitis

Disease Ontology : 12 A dermatitis that is an inflammatory skin condition resulting in flaky, white to yellowish scales on oily areas such as the scalp or inside the ear, which is caused due to a combination of an over production of skin oil and irritation from a yeast Malassezia furfur. The symptoms include itching, skin lesions and scales, redness, plaques and hair loss.

MalaCards based summary : Seborrheic Dermatitis, also known as seborrhoeic dermatitis, is related to seborrhea-like dermatitis with psoriasiform elements and seborrheic infantile dermatitis. An important gene associated with Seborrheic Dermatitis is BTD (Biotinidase), and among its related pathways/superpathways is DAG and IP3 signaling. The drugs Isotretinoin and Salicylic acid have been mentioned in the context of this disorder. Affiliated tissues include skin, testes and ovary, and related phenotypes are Increased shRNA abundance (Z-score > 2) and Increased shRNA abundance (Z-score > 2)

Wikipedia : 76 Seborrhoeic dermatitis, also known as seborrhoea, is a long-term skin disorder. Symptoms include red,... more...

Related Diseases for Seborrheic Dermatitis

Diseases in the Seborrheic Dermatitis family:

Seborrheic Infantile Dermatitis

Diseases related to Seborrheic Dermatitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 38)
# Related Disease Score Top Affiliating Genes
1 seborrhea-like dermatitis with psoriasiform elements 12.4
2 seborrheic infantile dermatitis 12.1
3 garret tripp syndrome 11.1
4 keratosis, seborrheic 10.9
5 dermatitis 10.8
6 psoriasis 10.2
7 penis agenesis 10.2 AHR CGA
8 dermatitis, atopic 10.1
9 complete androgen insensitivity syndrome 10.1 CGA SHBG
10 pityriasis versicolor 10.1
11 androgen insensitivity syndrome 10.1 CGA SHBG
12 tinea capitis 10.0
13 gynecomastia 10.0 CGA SHBG
14 rosacea 9.9
15 anovulation 9.9 CGA SHBG
16 varicocele 9.8 CGA SHBG
17 aging 9.8
18 keratopathy 9.8
19 skin disease 9.8
20 lymphoma 9.8
21 alexithymia 9.8
22 sarcoma 9.8
23 fissured tongue 9.8
24 oral candidiasis 9.8
25 geographic tongue 9.8
26 candidiasis 9.8
27 contact dermatitis 9.8
28 syringomyelia 9.8
29 erythrasma 9.8
30 folliculitis 9.8
31 bronchitis 9.8
32 lymphosarcoma 9.8
33 pityriasis rosea 9.8
34 blepharitis 9.8
35 aminoaciduria 9.8
36 pyridoxine deficiency 9.8
37 keratosis 9.7
38 testicular cancer 9.6 CGA SHBG

Graphical network of the top 20 diseases related to Seborrheic Dermatitis:



Diseases related to Seborrheic Dermatitis

Symptoms & Phenotypes for Seborrheic Dermatitis

GenomeRNAi Phenotypes related to Seborrheic Dermatitis according to GeneCards Suite gene sharing:

26 (show all 15)
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Increased shRNA abundance (Z-score > 2) GR00366-A-100 9.55 SLCO2A1
2 Increased shRNA abundance (Z-score > 2) GR00366-A-146 9.55 ATP2A2
3 Increased shRNA abundance (Z-score > 2) GR00366-A-169 9.55 ATP2A2 SHBG SLCO2A1
4 Increased shRNA abundance (Z-score > 2) GR00366-A-174 9.55 ATP2A2
5 Increased shRNA abundance (Z-score > 2) GR00366-A-19 9.55 ATP2A2
6 Increased shRNA abundance (Z-score > 2) GR00366-A-207 9.55 SHBG
7 Increased shRNA abundance (Z-score > 2) GR00366-A-21 9.55 SLCO2A1
8 Increased shRNA abundance (Z-score > 2) GR00366-A-214 9.55 SLCO2A1
9 Increased shRNA abundance (Z-score > 2) GR00366-A-29 9.55 ATP2A2
10 Increased shRNA abundance (Z-score > 2) GR00366-A-35 9.55 ATP2A2
11 Increased shRNA abundance (Z-score > 2) GR00366-A-36 9.55 ATP2A2
12 Increased shRNA abundance (Z-score > 2) GR00366-A-45 9.55 SHBG
13 Increased shRNA abundance (Z-score > 2) GR00366-A-46 9.55 SHBG
14 Increased shRNA abundance (Z-score > 2) GR00366-A-69 9.55 SHBG
15 Increased shRNA abundance (Z-score > 2) GR00366-A-8 9.55 SLCO2A1

MGI Mouse Phenotypes related to Seborrheic Dermatitis:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 9.43 AHR ATP2A2 IDH2 MPZL3 SLCO2A1 STK4
2 renal/urinary system MP:0005367 9.02 AHR ATP2A2 BTD MPZL3 SLCO2A1

Drugs & Therapeutics for Seborrheic Dermatitis

Drugs for Seborrheic Dermatitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 119)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Isotretinoin Approved Phase 4 4759-48-2 5538 5282379
2
Salicylic acid Approved, Investigational, Vet_approved Phase 4 69-72-7 338
3
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Not Applicable 22916-47-8 4189
4
Ciclopirox Approved, Investigational Phase 4,Phase 3 29342-05-0 2749
5
Benzoyl peroxide Approved Phase 4,Phase 1,Phase 2 94-36-0 7187
6
Norgestrel Approved Phase 4 6533-00-2 13109
7
Moxifloxacin Approved, Investigational Phase 4 354812-41-2, 151096-09-2 152946
8
Drospirenone Approved Phase 4 67392-87-4 68873
9
Desogestrel Approved Phase 4 54024-22-5 40973
10 Estradiol valerate Approved, Investigational, Vet_approved Phase 4 979-32-8
11
Tacrolimus Approved, Investigational Phase 4,Phase 3 104987-11-3 445643 439492
12
Norgestimate Approved, Investigational Phase 4 35189-28-7 6540478
13
Estradiol Approved, Investigational, Vet_approved Phase 4 50-28-2 5757
14
Ketoconazole Approved, Investigational Phase 4,Phase 3,Not Applicable 65277-42-1 47576 3823
15
Ethinyl Estradiol Approved Phase 4 57-63-6 5991
16
Polyestradiol phosphate Approved Phase 4 28014-46-2
17
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4 59-30-3 6037
18 Analgesics Phase 4,Phase 2,Phase 1
19 Salicylates Phase 4
20 Cyclooxygenase Inhibitors Phase 4
21 Analgesics, Non-Narcotic Phase 4,Phase 2,Phase 1
22 Hormone Antagonists Phase 4,Phase 3,Not Applicable
23 Dermatologic Agents Phase 4,Phase 2,Phase 1,Not Applicable
24 Hormones Phase 4,Phase 3,Not Applicable
25 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 3,Not Applicable
26 Emollients Phase 4,Not Applicable
27 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 2,Phase 1
28 Anti-Infective Agents Phase 4,Phase 3,Not Applicable
29 Antifungal Agents Phase 4,Phase 3,Not Applicable
30 Keratolytic Agents Phase 4
31 Anti-Inflammatory Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
32 Anti-Inflammatory Agents, Non-Steroidal Phase 4,Phase 2,Phase 1
33 Antirheumatic Agents Phase 4,Phase 2,Phase 1
34 Progestins Phase 4
35 insulin Phase 4
36 diuretics Phase 4
37 Fluoroquinolones Phase 4
38 Micronutrients Phase 4
39 Mineralocorticoid Receptor Antagonists Phase 4
40 Mineralocorticoids Phase 4
41 Natriuretic Agents Phase 4
42 Steroid Synthesis Inhibitors Phase 4,Phase 3,Not Applicable
43 Contraceptive Agents Phase 4,Phase 1,Phase 2
44 Contraceptives, Oral Phase 4
45 Contraceptives, Oral, Combined Phase 4
46 Cytochrome P-450 CYP3A Inhibitors Phase 4,Phase 3,Not Applicable
47 Cytochrome P-450 Enzyme Inhibitors Phase 4,Phase 3,Not Applicable
48 Topoisomerase Inhibitors Phase 4
49 Norgestimate, ethinyl estradiol drug combination Phase 4
50 Trace Elements Phase 4

Interventional clinical trials:

(show all 37)
# Name Status NCT ID Phase Drugs
1 Efficacy and Safety of Low-dose Oral Isotretinoin for Seborrhea Unknown status NCT01139749 Phase 4 oral isotretinoin;salicylic acid and ciclopirox olamine
2 Promiseb Topical Cream for Cradle Cap Completed NCT01214434 Phase 4
3 Proactive Treatment of Tacrolimus Ointment for Adult Facial Seborrheic Dermatitis Completed NCT01591070 Phase 4 Tacrolimus;Tacrolimus
4 STUDY TO ASSESS THE LONG-TERM SAFETY OF EXTINA (KETOCONAZOLE) FOAM, 2% Completed NCT00703846 Phase 4 Ketoconazole
5 Safety and Efficacy of Ketoconazole 2% Foam in the Treatment of Pityrosporum Folliculitis Completed NCT00824863 Phase 4 ketoconazole 2% foam
6 Clinical, Metabolic and Endocrine Effects of the Treatment With Drospirenone and Ethinyl Estradiol Alone or in Combination With Myo-inositol in Young Women With Polycystic Ovary Syndrome (PCOS) and Insulin Resistance Completed NCT01511822 Phase 4 Drospirenone Ethinyl estradiol;Drospirenone Ethinyl estradiol Myo-inositol;placebo
7 An Efficacy and Safety Study Comparing Oral Contraceptive Containing Norgestimate or Desogestrel for Acne Treatment Completed NCT01466673 Phase 4 Ethinyl estradiol/Norgestimate (EE/NGM);Ethinyl estradiol/Desogestrel (EE/DSG)
8 A Proof of Concept Clinical Trial Evaluating the Safety and Efficacy of Eucrisa (Crisaborole) in Patients With Seborrheic Dermatitis Not yet recruiting NCT03567980 Phase 4 Crisaborole
9 Efficacy and Tolerability of Prednisolone Acetate 0.5% Cream Versus Betamethasone Valerate 0.1% Cream in Cortisosensitive Dermatosis Unknown status NCT01011621 Phase 3 0.5% prednisolone acetate cream;0.1% betamethasone valerate cream
10 Tacrolimus Ointment Interest (PROTOPIC ®) in the Maintenance Treatment of Severe Seborrheic Dermatitis Completed NCT02004860 Phase 3 Protopic (R);Mycoster (R)
11 Clobetasol Propionate 0.05% Shampoo in Association With Antifungal Shampoo in Scalp Seborrheic Dermatitis Completed NCT00862654 Phase 3 clobetasol propionate shampoo (4/week) - ketoconazole shampoo (2/week);clobetasol propionate shampoo (2/week) - ketoconazole shampoo (2/week);clobetasol propionate shampoo (2/week);ketoconazole shampoo (2/week)
12 Efficacy and Safety of ASF1057 in the Treatment of Seborrhoeic Dermatitis Completed NCT00565279 Phase 3 ASF1057;ASF1057
13 Two Topical K40 Formulations in Adults With Seborrhoeic Dermatitis (SD) of the Scalp Completed NCT01137630 Phase 2, Phase 3 K40a;K40b;Placebo
14 K301 for the Treatment of Seborrhoeic Eczema (SE) of the Scalp Completed NCT01137331 Phase 3 K301;Placebo
15 A 4 Week Study of Elidel for the Treatment of Seborrheic Dermatitis Completed NCT00403559 Phase 2 Elidel
16 A Study of Azelaic Acid (AzA) 15% Gel in the Treatment of Seborrheic Dermatitis of the Face Completed NCT00408330 Phase 2 Azelaic Acid 15% Gel;Inactive 15% gel base
17 A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Seborrheic Dermatitis Completed NCT02749383 Phase 2 PAC-14028 cream 0.3%;PAC-14028 cream 1.0%;PAC-14028 cream vehicle
18 Safety and Efficacy Study in Subjects With Seborrheic Dermatitis Completed NCT01703793 Phase 2 Test Product 49778;Test Product 10156;Vehicle (placebo)
19 Proof of Concept Study of MTC896 Gel to Reduce Sebum Production on the Forehead of Healthy Male Volunteers Completed NCT01254162 Phase 2 MTC896 Gel
20 The Role of Topically Dissolved Oxygen (TDO) to Ameliorate Signs of Photodamage Completed NCT00991198 Phase 2 Topical oxygen;Topical oxygen;placebo
21 Pirfenidone Plus M-DDO Gel in Moderate and Severe Acne Recruiting NCT03076320 Phase 1, Phase 2
22 A Study of Tolerability and Efficacy of Cannabidiol on Motor Symptoms in Parkinson's Disease Not yet recruiting NCT03582137 Phase 2 Cannabidiol
23 Botulinum Toxin for Treatment of Seborrhic Dermatitis in Parkinsonian Patients Unknown status NCT00767546 Phase 1 Botulinum toxin
24 Petrolatum's Effect on Initial Symptoms of Nonscalp Seborrheic Dermatitis and Preventing Exacerbation Unknown status NCT01315951 Not Applicable
25 Evaluation of the Effectiveness of a Product Containing Topical Hydrocortisone in the Treatment of Seborrheic Dermatitis of the Face Unknown status NCT01024374
26 HIV Indicator Diseases Across Europe Study Unknown status NCT01681706
27 HIV Indicator Diseases Survey Across Europe - UK Arm Unknown status NCT01196468
28 Neurobiology of the Scalp in Seborrheic Dermatitis Completed NCT02349854
29 HairMax LaserComb Open Label Study to Treat Seborrheic Dermatitis Completed NCT00830908 Not Applicable
30 Safety and Efficacy of SEBORRHEAMEDIS Face Cream in Patients With Seborrheic Dermatitis Completed NCT02656368 Not Applicable
31 Seborrheic Dermatitis: Ketoconazole 2% Foam Versus Ketoconazole 2% Shampoo Completed NCT01203189 Not Applicable ketoconazole 2% foam;ketoconazole 2% shampoo
32 An Investigator-Initiated Study to Assess the Cooling Effect of Triamcinolone Acetonide Aerosol When Used for Steroid-Responsive Dermatoses Completed NCT01736670 Not Applicable Triamcinolone Acetonide spray;Triamcinolone acetonide cream;Alcohol spray
33 Furocyst - Poly Cystic Ovary Syndrome Study Completed NCT02703064 Not Applicable
34 Drug Utilization Study on Diane-35 (and Generics) in Three European Healthcare Databases Completed NCT02349399 Cyproterone / Ethinylestradiol (Diane-35, BAY86-5264) and its Generics
35 Drug Utilization Study on the Prescribing Indications for Cyproterone Acetate and Ethinyl Estradiol in 5 European Countries Recruiting NCT02494297
36 Pilot Study for the Use of Photodynamic Therapy in the Treatment of Seborrheic Dermatitis Active, not recruiting NCT03114111 Not Applicable aminolevulinic acid (ALA);Placebo
37 Polymorphism of Extrapituitary Promoter of PRL Gene and Relationships With Serum Prolactin Levels in Acne Vulgaris. Not yet recruiting NCT03186222

Search NIH Clinical Center for Seborrheic Dermatitis

Inferred drug relations via UMLS 73 / NDF-RT 51 :


Cochrane evidence based reviews: dermatitis, seborrheic

Genetic Tests for Seborrheic Dermatitis

Genetic tests related to Seborrheic Dermatitis:

# Genetic test Affiliating Genes
1 Seborrheic Dermatitis 29

Anatomical Context for Seborrheic Dermatitis

MalaCards organs/tissues related to Seborrheic Dermatitis:

41
Skin, Testes, Ovary, Tongue, T Cells, Colon

Publications for Seborrheic Dermatitis

Articles related to Seborrheic Dermatitis:

(show top 50) (show all 85)
# Title Authors Year
1
Chronic Nasolabial Fold Seborrheic Dermatitis Successfully Controlled With Crisaborole. ( 29742192 )
2018
2
Treatment of seborrheic dermatitis: a comprehensive review. ( 29737895 )
2018
3
<i>Staphylococcus aureus</i> is the most common bacterial agent of the skin flora of patients with seborrheic dermatitis. ( 29785324 )
2018
4
Scalp Seborrheic Dermatitis and Dandruff Therapy Using a Herbal and Zinc Pyrithione-based Therapy of Shampoo and Scalp Lotion. ( 29410727 )
2018
5
Topical Medications for Seborrheic Dermatitis. ( 28290646 )
2017
6
Dasatinib-induced Seborrheic Dermatitis-like Eruption. ( 29104720 )
2017
7
Intertriginous and Seborrheic Dermatitis-Like Lesions in an Endocrine Patient. ( 29210714 )
2017
8
Prevalence and determinants of seborrheic dermatitis in a middle aged and elderly population: the Rotterdam Study. ( 28856679 )
2017
9
A novel cosmetic antifungal/anti-inflammatory topical gel for the treatment of mild to moderate seborrheic dermatitis of the face: an open-label trial utilizing clinical evaluation and erythema-directed digital photography. ( 28121079 )
2017
10
Cutaneous fungal microbiome: <i>Malassezia</i> yeasts in seborrheic dermatitis scalp in a randomized, comparative and therapeutic trial. ( 29484095 )
2017
11
The genetics of seborrheic dermatitis: a candidate gene approach and pilot genome-wide association study. ( 29203360 )
2017
12
Low-dose oral isotretinoin for moderate to severe seborrhea and seborrheic dermatitis: a randomized comparative trial. ( 27778328 )
2017
13
History of Seborrheic Dermatitis: Conceptual and Clinico-Pathologic Evolution. ( 28705278 )
2017
14
High Staphylococcus epidermidis Colonization and Impaired Permeability Barrier in Facial Seborrheic Dermatitis. ( 28685715 )
2017
15
Treatment of Seborrheic Dermatitis Using a Novel Herbal-based Cream. ( 28458770 )
2017
16
Hydrocortisone 1% cream and sertaconazole 2% cream to treat facial seborrheic dermatitis: A double-blind, randomized clinical trial. ( 28560305 )
2017
17
New perspectives on dandruff and seborrheic dermatitis: lessons we learned from bacterial and fungal skin microbiota. ( 28690211 )
2017
18
RF-Itraconazole Pulse Therapy for Seborrheic Dermatitis: A Treatment Approach to Consider. ( 28262107 )
2017
19
Comparison of different regimens of pimecrolimus 1% cream in the treatment of facial seborrheic dermatitis. ( 28589618 )
2017
20
Histopathological Differential Diagnosis of Psoriasis and Seborrheic Dermatitis of the Scalp. ( 27489423 )
2016
21
Loss of MPZL3 Function Causes Seborrheic Dermatitis-like Phenotype in Mice. ( 27488654 )
2016
22
Seborrheic dermatitis treatment with stellate ganglion block: a case report. ( 27064785 )
2016
23
Isolation and identification of Malassezia species from Chinese and Korean patients with seborrheic dermatitis and in vitro studies on their bioactivity on sebaceous lipids and IL-8 production. ( 26786542 )
2016
24
Diffuse HIV-associated seborrheic dermatitis - a case series. ( 27013615 )
2016
25
Comprehensive pyrosequencing analysis of the bacterial microbiota of the skin of patients with seborrheic dermatitis. ( 27301664 )
2016
26
Clinical manifestation and associated factors of seborrheic dermatitis in Korea. ( 26771150 )
2016
27
Noncorticosteroid Combination Shampoo versus 1% Ketoconazole Shampoo for the Management of Mild-to-Moderate Seborrheic Dermatitis of the Scalp: Results from a Randomized, Investigator-Single-Blind Trial Using Clinical and Trichoscopic Evaluation. ( 27171495 )
2016
28
Effect of itraconazole on the quality of life in patients with moderate to severe seborrheic dermatitis: a randomized, placebo-controlled trial. ( 27648378 )
2016
29
Malassezia arunalokei sp. nov., a Novel Yeast Species Isolated from Seborrheic Dermatitis Patients and Healthy Individuals from India. ( 27147721 )
2016
30
Efficacy and Safety of Cream Containing Climbazole/Piroctone Olamine for Facial Seborrheic Dermatitis: A Single-Center, Open-Label Split-Face Clinical Study. ( 27904273 )
2016
31
Biofilm production and antifungal susceptibility of co-cultured Malassezia pachydermatis and Candida parapsilosis isolated from canine seborrheic dermatitis. ( 26868903 )
2016
32
Prevalence and related factors of psoriasis and seborrheic dermatitis: a community-based study. ( 27511489 )
2016
33
Topical Treatment of Facial Seborrheic Dermatitis: A Systematic Review. ( 27804089 )
2016
34
Metabolic syndrome may be an important comorbidity in patients with seborrheic dermatitis. ( 28905039 )
2016
35
Dermoscopic findings in scalp psoriasis and seborrheic dermatitis; two new signs; signet ring vessel and hidden hair. ( 25657395 )
2015
36
Seborrheic Dermatitis and Dandruff: A Comprehensive Review. ( 27148560 )
2015
37
Maintenance Therapy of Facial Seborrheic Dermatitis with 0.1% Tacrolimus Ointment. ( 26512166 )
2015
38
Plica polonica secondary to seborrheic dermatitis. ( 26456757 )
2015
39
Evaluation of a Topical Anti-inflammatory/Antifungal Combination Cream in Mild-to-moderate Facial Seborrheic Dermatitis: An Intra-subject Controlled Trial Examining Treated vs. Untreated Skin Utilizing Clinical Features and Erythema-directed Digital Photography. ( 26430489 )
2015
40
Diagnosis and treatment of seborrheic dermatitis. ( 25822272 )
2015
41
Topical anti-inflammatory agents for seborrheic dermatitis of the face or scalp: summary of a Cochrane Review. ( 25629391 )
2015
42
Efficacy of Oral Itraconazole in the Treatment and Relapse Prevention of Moderate to Severe Seborrheic Dermatitis: A Randomized, Placebo-Controlled Trial. ( 26016699 )
2015
43
Clinical Characteristics and Quality of Life of Seborrheic Dermatitis Patients in a Tropical Country. ( 26538714 )
2015
44
Infantile seborrheic dermatitis: a pediatric Siddha medicine treatise. ( 25889138 )
2015
45
Malassezia intra-specific diversity and potentially new species in the skin microbiota from Brazilian healthy subjects and seborrheic dermatitis patients. ( 25695430 )
2015
46
Refractory seborrheic dermatitis of the head in a patient with malignant lymphoma. ( 25566053 )
2014
47
Clinical Evaluation of a New-Formula Shampoo for Scalp Seborrheic Dermatitis Containing Extract of Rosa centifolia Petals and Epigallocatechin Gallate: A Randomized, Double-Blind, Controlled Study. ( 25473226 )
2014
48
Red face revisited: Endogenous dermatitis in the form of atopic dermatitis and seborrheic dermatitis. ( 24314384 )
2014
49
Reflectance confocal microscopy features of seborrheic dermatitis for plaque psoriasis differentiation. ( 25323385 )
2014
50
Utilization of matrix-assisted laser desorption and ionization time-of-flight mass spectrometry for identification of infantile seborrheic dermatitis-causing Malassezia and incidence of culture-based cutaneous Malassezia microbiota of 1-month-old infants. ( 24387229 )
2014

Variations for Seborrheic Dermatitis

Expression for Seborrheic Dermatitis

Search GEO for disease gene expression data for Seborrheic Dermatitis.

GO Terms for Seborrheic Dermatitis

Biological processes related to Seborrheic Dermatitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 negative regulation of organ growth GO:0046621 8.62 CGA STK4

Sources for Seborrheic Dermatitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....